Stocks Rally on Hopes of Trade Deals
The stock market indexes showed positive momentum today, with the S&P 500, Dow Jones Industrials, and Nasdaq 100 all posting gains. The S&P 500 reached a new all-time high, while the Dow Jones hit a 3-3/4 month high. This surge in stocks was attributed to positive trade news, as the US moves closer to reaching trade deals with China and other trading partners.
The University of Michigan’s US June consumer sentiment index also provided a boost to the market, showing an improvement in consumer sentiment and a decline in inflation expectations. Despite weaker-than-expected US May personal spending and income reports, as well as a stronger-than-expected May core PCE price index, stocks continued to climb.
US Commerce Secretary Lutnick announced that the US and China had finalized a trade understanding, with China committing to delivering rare earth materials. This agreement, along with plans to reach agreements with other major trading partners, helped lift investor confidence.
Minneapolis Fed President Kashkari suggested that there could be two 25-bp Fed rate cuts this year, with the first potentially happening in September. However, he also warned about the potential impact of tariffs on inflation, emphasizing the need for policymakers to remain flexible.
Looking ahead, the upcoming earnings season in two weeks may present challenges for the market. Consensus data show a modest increase in Q2 earnings for S&P 500 companies, with only six out of the 11 sectors projected to post growth.
In terms of interest rates, T-note prices saw a slight decline today due to positive trade news and the stronger-than-expected May core PCE price index. However, losses were limited by the unexpected declines in US May personal spending and income reports, as well as dovish comments from Fed officials.
Overall, the stock market remains buoyant, with chip makers and companies like Nike, Apogee Enterprises, and Trade Desk showing strong performance. However, gold mining stocks and companies like Coinbase Global and CorMedix faced declines. The market will continue to monitor trade developments and economic data for further direction.
